Glucagon‐like peptide‐2 mobilizes lipids from the intestine by a systemic nitric oxide‐independent mechanism.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2535, doi. 10.1111/dom.13839
- By:
- Publication type:
- Article
Works by Morgantini, Cecilia
Results: 14
1
2
Influence of apolipoproteins on the association between lipids and insulin sensitivity: a cross-sectional analysis of the RISC Study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
3
Influence of Apolipoproteins on the Association Between Lipids and Insulin Sensitivity.
- Published in:
- Diabetes Care, 2013, v. 36, n. 12, p. 4125, doi. 10.2337/dc13-0682
- By:
- Publication type:
- Article
4
Macrophage‐derived insulin antagonist ImpL2 induces lipoprotein mobilization upon bacterial infection.
- Published in:
- EMBO Journal, 2023, v. 42, n. 23, p. 1, doi. 10.15252/embj.2023114086
- By:
- Publication type:
- Article
5
Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol.
- Published in:
- 2016
- By:
- Publication type:
- journal article
6
Evaluation of the Effect of Enteral Lipid Sensing on Endogenous Glucose Production in Humans.
- Published in:
- Diabetes, 2015, v. 64, n. 8, p. 2939, doi. 10.2337/db15-0148
- By:
- Publication type:
- Article
7
Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism.
- Published in:
- Diabetes, 2015, v. 64, n. 7, p. 2310, doi. 10.2337/db14-1706
- By:
- Publication type:
- Article
8
Intranasal Insulin Suppresses Endogenous Glucose Production in Humans Compared With Placebo in the Presence of Similar Venous Insulin Concentrations.
- Published in:
- Diabetes, 2015, v. 64, n. 3, p. 766, doi. 10.2337/db14-0685
- By:
- Publication type:
- Article
9
Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy Humans.
- Published in:
- Diabetes, 2014, v. 63, n. 7, p. 2394, doi. 10.2337/db13-1654
- By:
- Publication type:
- Article
10
Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes.
- Published in:
- Diabetes, 2011, v. 60, n. 10, p. 2617, doi. 10.2337/db11-0378
- By:
- Publication type:
- Article
11
Apolipoprotein A-I Mimetic Peptides Prevent Atherosclerosis Development and Reduce Plaque Inflammation in a Murine Model of Diabetes.
- Published in:
- Diabetes, 2010, v. 59, n. 12, p. 3223, doi. 10.2337/db10-0844
- By:
- Publication type:
- Article
12
Reducing Cholesterol and Fat Intake Improves Glucose Tolerance by Enhancing β Cell Function in Nondiabetic Subjects.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2018, p. 622, doi. 10.1210/jc.2017-02089
- By:
- Publication type:
- Article
13
Reducing Cholesterol and Fat Intake Improves Glucose Tolerance by Enhancing β Cell Function in Nondiabetic Subjects.
- Published in:
- 2017
- By:
- Publication type:
- journal article
14
Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 532, p. 1, doi. 10.1126/scitranslmed.aaw9709
- By:
- Publication type:
- Article